| 49250-4 |
Amino acids |
Imp |
Urine |
Pt |
Nar |
|
|
DEPRECATED |
Deprecated Amino acids [interpretation] in Urine Narrative |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49250-4 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Amino acids Ur-Imp |
|
|
|
N |
|
AA; Acd; Acid; Amino acid; Amino acids.total; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.48 |
2.21 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 49251-2 |
Amylase isoenzymes |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Amylase isoenzymes [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49251-2 |
|
|
|
|
Observation |
|
|
|
0 |
Amylase Isos SerPl-Imp |
|
|
|
N |
|
Alpha amylase; Ams; Amyl; Amylase Isos; Chemistry; Diastase; Gastro; Gastroenterology; GI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; ISO; Isoamy; Isoamylase; Isoen; Isoenzyme; k87; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49252-0 |
Calculus analysis |
Imp |
Calculus |
Pt |
Nar |
|
|
ACTIVE |
Calculus analysis [Interpretation] in Stone Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49252-0 |
|
|
|
|
Observation |
|
|
|
0 |
Stone Analysis-Imp |
|
|
|
N |
|
Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Narrative; Nephrology; Point in time; Random; Renal; Report; Stn; Stone; Stone Analysis; Stones |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49253-8 |
Beta-N-acetylhexosaminidase A & B |
Imp |
Bld |
Pt |
Nar |
|
|
ACTIVE |
Beta-N-acetylhexosaminidase A and B [Interpretation] in Blood Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49253-8 |
|
|
|
|
Observation |
|
|
|
0 |
Hexosaminidase A & B Bld-Imp |
|
|
|
N |
|
A,B; B; Beta-hexosaminidase subunit alpha; Blood; B-NAH; Chemistry; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase A; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Sandhoff disease; Sandhoff Disease, Adult; Tay Sachs Disease; Tay-Sachs disease; WB; Whole blood |
2.38 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49254-6 |
Bile acid pattern |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Bile acid pattern [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49254-6 |
|
|
|
|
Observation |
|
|
|
0 |
Bile Ac Pattern Ur-Imp |
|
|
|
N |
|
Acd; Acids; Bile Ac Pattern; Bile acid.total; Bile salt; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49255-3 |
Calculus analysis |
Imp |
Calculus |
Pt |
Nar |
Infrared spectroscopy |
|
ACTIVE |
Calculus analysis [Interpretation] in Stone Narrative by Infrared spectroscopy |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49255-3 |
|
Infrared spectroscopy |
|
|
Both |
|
|
|
0 |
Stone Analysis IR-Imp |
|
|
|
N |
|
Calc; Calculi; Chemistry; Gastro; Gastroenterology; GI; Impression; Impression/interpretation of study; Impressions; Infared spectoscopy; Interp; Interpretation; IR; Kidney; Narrative; Nephrology; Point in time; Random; Renal; Report; Stn; Stone; Stone Analysis; Stones; UniversalLabOrders |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49256-1 |
Catecholamines |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Catecholamines [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49256-1 |
|
|
|
|
Observation |
|
|
|
0 |
Catechols Ur-Imp |
|
|
|
N |
|
Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49257-9 |
Catecholamines |
Imp |
Plas |
Pt |
Nar |
|
|
ACTIVE |
Catecholamines [Interpretation] in Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49257-9 |
|
|
|
|
Observation |
|
|
|
0 |
Catechols Plas-Imp |
|
|
|
N |
|
Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; Chemistry; Epinephrine+norepinephrine+dopamine; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49258-7 |
Creatine kinase isoenzymes |
Imp |
Ser/Plas |
Pt |
Nar |
Electrophoresis |
|
ACTIVE |
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49258-7 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
CK Isos SerPl Elph-Imp |
|
|
|
N |
|
Cardio; Cardiology; Chemistry; CK; CK Isos; CPK; Creatine phosphokinase; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Heart Disease; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; ISO; Isoen; Isoenzyme; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49259-5 |
Creatine kinase isoenzymes |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Creatine kinase isoenzymes [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49259-5 |
|
|
|
|
Observation |
|
|
|
0 |
CK Isos SerPl-Imp |
|
|
|
N |
|
Cardio; Cardiology; Chemistry; CK; CK Isos; CPK; Creatine phosphokinase; Heart Disease; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; ISO; Isoen; Isoenzyme; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4926-2 |
HLA-DPw4 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw4 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4926-2 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw4 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49260-3 |
Cryoglobulin IgA & IgG & IgM |
Imp |
Ser |
Pt |
Nar |
|
|
ACTIVE |
Cryoglobulin IgA and IgG and IgM [Interpretation] in Serum Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49260-3 |
|
|
|
|
Observation |
|
|
|
0 |
Cryoglob IgA & IgG & IgM Ser-Imp |
|
|
|
N |
|
Chemistry; Cryo; Cryoglob IgA; Cryoglob IgA & IgG & IgM; Cryoglobulins; Cryoprecipitate; Immune globulin A; Immune globulin G; Immune globulin M; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Serum; SR |
2.38 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49261-1 |
Cryoproteins |
Imp |
Ser |
Pt |
Nar |
Electrophoresis.agarose gel |
|
ACTIVE |
Cryoproteins [Interpretation] in Serum by Electrophoresis agarose gel Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49261-1 |
|
Electrophoresis.agarose gel |
|
|
Observation |
|
|
|
0 |
Cryoproteins Ser AG Elph-Imp |
|
|
|
N |
|
AG Elph; Chemistry; Cryoprotein; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Serum; SR |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49262-9 |
Fatty acids pattern |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Fatty acids pattern [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49262-9 |
|
|
|
|
Observation |
|
|
|
0 |
Fatty acids pattern SerPl-Imp |
|
|
|
N |
|
Acd; Acid; Chemistry; Fatty acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lipid; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49263-7 |
Fatty acids.very long chain pattern |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Fatty acids.very long chain pattern [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49263-7 |
|
|
|
|
Observation |
|
|
|
0 |
VLCFA Pattern SerPl-Imp |
|
|
|
N |
|
Acd; Acid; Aliphatic carboxylate; Chains; Chemistry; Chn; Fatty acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lipid; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VLC; VLCF; VLCFA; VLCFA Pattern |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49264-5 |
Folate+Cyanocobalamin |
Imp |
Ser/Bld |
Pt |
Nar |
|
|
ACTIVE |
Folate+Cyanocobalamin [Interpretation] in Serum or Blood Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49264-5 |
|
|
|
|
Observation |
|
|
|
0 |
Folate+Vit B12 SerBld-Imp |
|
|
|
N |
|
Blood; c133; Chemistry; CN-Cbl; Folat; Folate+Vit B12; Folic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Pteroylglutamate; Pteroylglutamic acid; Random; Report; SerBld; Serum; Serum or whole blood; SR; Vit B12; Vit M; Vitamin B12; Vitamin M; WB; Whole blood |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49265-2 |
Gammopathy |
Imp |
Ser |
Pt |
Nar |
Electrophoresis |
|
ACTIVE |
Gammopathy [Interpretation] in Serum by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49265-2 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Gammopathy Ser Elph-Imp |
|
|
|
N |
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Serum; SR |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49266-0 |
Glucose-6-Phosphate dehydrogenase phenotype |
Imp |
RBC |
Pt |
Nar |
|
|
ACTIVE |
Glucose-6-Phosphate dehydrogenase phenotype [Interpretation] in Red Blood Cells Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49266-0 |
|
|
|
|
Observation |
|
|
|
0 |
G6PD Phenotyp RBC-Imp |
|
|
|
N |
|
Chemistry; Dehydrog; Dehyrdogenase; Erythrocytes; G6PD; G-6-PD; G6PD Phenotyp; G6PDH; Glu; Gluc; Glucose-6-PD; Glucose-6-PDH; Glucoseur; GPD; i Phos; Impression; Impression/interpretation of study; Impressions; Inorganic phosphate; Interp; Interpretation; Narrative; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; Random; Red blood cells; Red blood corpusles; Report |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49267-8 |
Glutathione reductase phenotype |
Imp |
RBC |
Pt |
Nar |
|
|
ACTIVE |
Glutathione reductase phenotype [Interpretation] in Red Blood Cells Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49267-8 |
|
|
|
|
Observation |
|
|
|
0 |
GR Phenotyp RBC-Imp |
|
|
|
N |
|
Chemistry; Erythrocytes; GR; GR Phenotyp; GSR; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Red blood cells; Red blood corpusles; Report |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49268-6 |
Glycosaminoglycans pattern |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Glycosaminoglycans pattern [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49268-6 |
|
|
|
|
Observation |
|
|
|
0 |
GAG Pattern Ur-Imp |
|
|
|
N |
|
Chemistry; GAG; GAG Pattern; GAGS; Glycosaminoglycan; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MPS; Mucopolysaccharides; Mucopolysach; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49269-4 |
Homovanillate & Creatinine |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Homovanillate and Creatinine [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49269-4 |
|
|
|
|
Observation |
|
|
|
0 |
HVA & Creat Ur-Imp |
|
|
|
N |
|
3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; CR; Crea; Creat; Homovanilic; Homovanillic acid; HVA; HVA & Creat; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Tumor marker; UA; UCr; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4927-0 |
HLA-DPw4 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw4 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4927-0 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw4 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49270-2 |
Immunoglobulin light chains |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Immunoglobulin light chains [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49270-2 |
|
|
|
|
Observation |
|
|
|
0 |
BJ Protein Ur-Imp |
|
|
|
N |
|
Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Impression; Impression/interpretation of study; Impressions; Imunoglbon; Imunoglobn; Interp; Interpretation; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49271-0 |
Interpretation |
Imp |
CSF |
Pt |
Nar |
Immunofixation |
|
ACTIVE |
Immunofixation for Cerebral spinal fluid Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49271-0 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Interpretation CSF IFE-Imp |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.54 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49272-8 |
Interpretation |
Imp |
CSF |
Pt |
Nar |
Immunoelectrophoresis |
|
ACTIVE |
Immunoelectrophoresis for Cerebral spinal fluid Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49272-8 |
|
Immunoelectrophoresis |
|
|
Observation |
|
|
|
0 |
Interpretation CSF IEP-Imp |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; IEP; Imm elect; Immunoelect; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.54 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
